AdvaMed Commends Administration Investment in Domestic Semiconductor Chip Manufacturing – AdvaMed

WASHINGTON – Advamed President and CEO Scott Whitaker released a statement following the Biden Administration’s CHIPS investment announcement in Oregon and Colorado:
“The investments being made in our domestic semiconductor chip manufacturing base under the CHIPS and Science Act are critical for the medtech industry and the millions of patients who rely on the life-saving devices the medtech industry develops. The reality is, our health care system and the delivery of patient care depends on a stable supply of mature semiconductor chips, and any disruption could be the difference between life and death for an untold number of patients.
“The announcement this week on the proposed CHIPS investments in Oregon and Colorado is a welcome sign that we are on the right trajectory to prevent future semiconductor supply strains laid bare by the pandemic. We look forward to working with the administration and chips manufactures to ensure the health care industry, and especially the medtech sector, remain a top priority.”
The CHIPS and Science Act included $52 billion in investments and incentives to bolster domestic manufacturing of semiconductor chips, which AdvaMed has championed since the onset of the pandemic and in the face of the growing supply chain challenges facing the medtech industry. Despite being less than one percent of the overall semiconductor chip market, manufacturers of medical devices and diagnostics rely primarily on mature semiconductor chips for a vast array of technologies.
Deloitte  released the findings of a follow-up survey, commissioned by AdvaMed, of medical device manufacturers that found since the initial survey in July 2021, semiconductor disruptions continue across multiple chip types, and medtech companies are more pessimistic, facing depleted inventory, reduced manufacturing, and extended lead times. The study found that medtech companies are doing their best to react to ongoing pressures, including by increasing stocking levels, seeking alternative sources of supply, and utilizing alternative transportation options. However, 75 percent of respondents reported that their customers are turning to alternative treatment types, alternate products, and new strategies.
News / Global & Trade
April 16, 2024
AdvaMed, the Medtech Association, released the following statement thanking the FDA Center for Radiological Health (CDRH) for recently hosting an event in New Delhi to discuss regulatory policies and best practices for ensuring medical technology reaches patients. The event, called “Minds to Markets: Regulatory Considerations in Med-Tech,” advances US-India cooperation on medtech supply chain through greater regulatory alignment.
News / Global & Trade
March 1, 2024
AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker regarding the conclusion of the World Trade Organization Ministerial conference in Abu Dhabi.
News / Global & Trade / Medical Imaging
January 22, 2024
Scott Whitaker, President and CEO of AdvaMed, the Medtech Association, urged the White House to delay the sale and privatization of the Federal Helium Reserve until concerns about resulting supply chain disruptions are resolved.
News / Global & Trade
January 19, 2024
AdvaMed President and CEO Scott Whitaker released the following statement regarding the 14th Ministerial-level Trade Policy Forum held in New Delhi, India:
Global & Trade

In times of crisis, the medtech industry stands as a pillar of strength, providing innovative solutions to address immediate needs and foster resilience. Discover a few NGOs that AdvaMed members can partner with to help make a positive impact around the world.
News / Government & Legislative Affairs / Supply Chain
January 4, 2024
In a new op-ed in RealClear Health, AdvaMed President and CEO Scott Whitaker called on the Biden Administration to ensure the medtech industry is considered as it implements policies to strengthen domestic supply chains.
News / Supply Chain
November 28, 2023
Today, AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the recent actions to strengthen supply chains announced by President Biden as part of the inaugural convening of the White House Council on Supply Chain Resilience:
News / Global & Trade
November 13, 2023
As the International Civil Aviation Organization (ICAO) Dangerous Goods Panel meets this week, AdvaMed, the Medtech Association, led a group of 24 global medtech organizations in expressing concerns about the panel’s proposed regulations on the transport of dangerous goods aboard aircraft.

Copyright 2024 AdvaMed

source

Facebook Comments Box

Trả lời

Email của bạn sẽ không được hiển thị công khai. Các trường bắt buộc được đánh dấu *